ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 992,87
0,18%
Dow Jones
38 686,32
1,51%
DAX
18 497,94
-0,09%
Brent Oil
81,295
0,00%
Bitcoin
67 528,04
-0,29%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Psychemedics Corporation (PMD)

  7. Psychemedics Corporation (PMD) Actualités

PMD

Psychemedics (PMD)

Psychemedics Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PMD
DateHeureSourceTitreSymboleSociété
14/05/202423h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PMDPsychemedics Corporation
14/05/202422h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PMDPsychemedics Corporation
14/05/202422h55GlobeNewswire Inc.Psychemedics Corporation Reports First Quarter 2024 Financial ResultsNASDAQ:PMDPsychemedics Corporation
28/03/202413h20GlobeNewswire Inc.Psychemedics Corporation Reports 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
21/03/202414h00GlobeNewswire Inc.Psychemedics Recognized as a Top 10 Employee Health Testing Services ProviderNASDAQ:PMDPsychemedics Corporation
13/02/202415h43Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PMDPsychemedics Corporation
24/01/202423h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
02/01/202417h27GlobeNewswire Inc.Psychemedics Corporation Announces Relocation of Headquarters to Dallas, TexasNASDAQ:PMDPsychemedics Corporation
19/12/202322h59Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PMDPsychemedics Corporation
14/12/202318h56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PMDPsychemedics Corporation
27/11/202315h00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:PMDPsychemedics Corporation
09/11/202323h00GlobeNewswire Inc.Psychemedics Corporation Reports Third Quarter 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
27/10/202317h00GlobeNewswire Inc.Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug ScreenNASDAQ:PMDPsychemedics Corporation
21/09/202323h00GlobeNewswire Inc.Psychemedics Corporation Appoints Shannon Shoemaker as Chief Revenue OfficerNASDAQ:PMDPsychemedics Corporation
22/08/202323h01Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PMDPsychemedics Corporation
18/08/202320h00GlobeNewswire Inc.Psychemedics Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PMDPsychemedics Corporation
17/08/202323h30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:PMDPsychemedics Corporation
11/08/202323h10GlobeNewswire Inc.Psychemedics Corporation Reports Second Quarter 2023 Financial ResultsNASDAQ:PMDPsychemedics Corporation
21/07/202322h15Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PMDPsychemedics Corporation
21/07/202322h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PMDPsychemedics Corporation
12/07/202323h15GlobeNewswire Inc.Psychemedics Corporation Announces CEO Succession PlanNASDAQ:PMDPsychemedics Corporation
25/05/202300h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PMDPsychemedics Corporation
11/05/202323h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PMDPsychemedics Corporation
09/05/202323h31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PMDPsychemedics Corporation
09/05/202323h30GlobeNewswire Inc.Psychemedics Corporation Reports First Quarter 2023 Financial Results and Declares Cash DividendNASDAQ:PMDPsychemedics Corporation
30/03/202323h16Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PMDPsychemedics Corporation
27/03/202316h02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PMDPsychemedics Corporation
21/03/202322h15GlobeNewswire Inc.Psychemedics Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Declares Quarterly Cash DividendNASDAQ:PMDPsychemedics Corporation
14/02/202323h22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PMDPsychemedics Corporation
09/11/202223h00GlobeNewswire Inc.Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash DividendNASDAQ:PMDPsychemedics Corporation
 Showing the most relevant articles for your search:NASDAQ:PMD

Dernières Valeurs Consultées

TG
INNA
ING Groep NV
ASX
YTMF14
Equity Trustees
POLO
GMXUSDT
GMX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés